Literature DB >> 10949545

IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.

K Asadullah1, A Haeussler-Quade, S Gellrich, S Hanneken, T E Hansen-Hagge, W D Döcke, H D Volk, W Sterry.   

Abstract

Cytokines are of major importance for the pathogenesis of cutaneous T-cell lymphomas (CTCL). Recent data suggested that IL-15 and IL-16 are survival/growth factors for the malignant T cells in these entities. To investigate the expression of IL-15 and IL-16 in mycosis fungoides (MF) and CD30+ pleomorphic T-cell lymphoma in vivo, we established a competitive RT-PCR technique. Analyzing skin biopsies from CTCL patients at different stages in comparison to psoriatic and healthy skin, we found IL-15 and IL-16 mRNA overexpression in both CTCL entities. Remarkably, there was some evidence for a stage-dependent increase during MF progression. We found only slight overexpression in early stage MF, when only few tumor cells are detectable within the infiltrates, whereas marked overexpression was found in more advanced lesions, which are characterized by a higher density of malignant cells. These results suggested that CTCL cells themselves might produce the cytokines. To further elucidate this hypothesis, two CTCL cell lines were analyzed but gave conflicting results. Therefore, the cellular origin of the IL-15 and IL-16 overexpression in CTCL remains unclear. Considering the significant overexpression of IL-15 and IL-16 and their biological capacities it is likely that these cytokines contribute to the tumor development. So, they might be involved in growth and skin homing of CTCL cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949545     DOI: 10.1034/j.1600-0625.2000.009004248.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

Review 1.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

2.  Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.

Authors:  Clara Curiel-Lewandrowski; Hisato Yamasaki; Chuan Ping Si; Xiaoyi Jin; Yujun Zhang; Jillian Richmond; Marina Tuzova; Kevin Wilson; Beth Sullivan; David Jones; Nataliya Ryzhenko; Frederick Little; Thomas S Kupper; David M Center; William W Cruikshank
Journal:  J Clin Invest       Date:  2011-11-14       Impact factor: 14.808

3.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation.

Authors:  Anjali Mishra; Shujun Liu; Gregory H Sams; Douglas P Curphey; Ramasamy Santhanam; Laura J Rush; Deanna Schaefer; Lauren G Falkenberg; Laura Sullivan; Laura Jaroncyk; Xiaojuan Yang; Harold Fisk; Lai-Chu Wu; Christopher Hickey; Jason C Chandler; Yue-Zhong Wu; Nyla A Heerema; Kenneth K Chan; Danilo Perrotti; Jianying Zhang; Pierluigi Porcu; Frederick K Racke; Ramiro Garzon; Robert J Lee; Guido Marcucci; Michael A Caligiuri
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

4.  Fine-mapping of IL16 gene and prostate cancer risk in African Americans.

Authors:  Ken Batai; Ebony Shah; Adam B Murphy; Jennifer Newsome; Maria Ruden; Chiledum Ahaghotu; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-24       Impact factor: 4.254

5.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

6.  IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).

Authors:  Andreas Willerslev-Olsen; Ivan V Litvinov; Simon M Fredholm; David L Petersen; Nina A Sibbesen; Robert Gniadecki; Qian Zhang; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Youwen Zhou; Anders Woetmann; Denis Sasseville; Thorbjørn Krejsgaard; Niels Odum
Journal:  Cell Cycle       Date:  2014-03-03       Impact factor: 4.534

7.  Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Authors:  Janet Y Li; Steven Horwitz; Alison Moskowitz; Patricia L Myskowski; Melissa Pulitzer; Christiane Querfeld
Journal:  Cancer Manag Res       Date:  2012-03-12       Impact factor: 3.989

Review 8.  Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.

Authors:  Thorbjørn Krejsgaard; Lise M Lindahl; Nigel P Mongan; Mariusz A Wasik; Ivan V Litvinov; Lars Iversen; Erik Langhoff; Anders Woetmann; Niels Odum
Journal:  Semin Immunopathol       Date:  2016-10-07       Impact factor: 9.623

9.  Association of functional IL16 polymorphisms with cancer and cardiovascular disease: a meta-analysis.

Authors:  Victor Hugo de Souza; Josiane Bazzo de Alencar; Bruna Tiaki Tiyo; Hugo Vicentin Alves; Evelyn Castillo Lima Vendramini; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Oncotarget       Date:  2020-09-08

Review 10.  Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma.

Authors:  Ping Zhang; Mingzhi Zhang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.